Li, Y., Zhang, G., Zhao, F., Li, R., Liu, S., Zhao, Z., & Wang, X. (2018). Target therapy of TRIM-14 inhibits osteosarcoma aggressiveness through the nuclear factor-κB signaling pathway. Exp Ther Med.
Styl ChicagoLi, Yi-Jiong, Guo-Ping Zhang, Feng Zhao, Rui-Qi Li, Shao-Jun Liu, Zeng-Ren Zhao, a Xin Wang. "Target Therapy of TRIM-14 Inhibits Osteosarcoma Aggressiveness Through the Nuclear Factor-κB Signaling Pathway." Exp Ther Med 2018.
Citace podle MLALi, Yi-Jiong, et al. "Target Therapy of TRIM-14 Inhibits Osteosarcoma Aggressiveness Through the Nuclear Factor-κB Signaling Pathway." Exp Ther Med 2018.
Upozornění: Tyto citace jsou generovány automaticky. Nemusí být zcela správně podle citačních pravidel..